| scholarly article | Q13442814 |
| P2093 | author name string | Wei Han | |
| Yue Han | |||
| Man Huang | |||
| Wenjuan Zhang | |||
| Changgeng Ruan | |||
| Zhaoyue Wang | |||
| Depei Wu | |||
| Lan Dai | |||
| Jiaqian Qi | |||
| Shixiang Zhao | |||
| Wenhong Shen | |||
| P2860 | cites work | Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis | Q29614337 |
| Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders | Q29618853 | ||
| Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation | Q33379387 | ||
| Increased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia | Q34560286 | ||
| Microparticles in hemostasis and thrombosis. | Q35131040 | ||
| Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease | Q36519690 | ||
| Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms | Q36946576 | ||
| Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia | Q37246729 | ||
| Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. | Q37331535 | ||
| Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review. | Q37418414 | ||
| Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. | Q37438142 | ||
| Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia | Q37625070 | ||
| Incidence Rates and Risk Factors for Vascular Events in Patients With Essential Thrombocythemia: A Multicenter Study From Korea | Q37956826 | ||
| Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management | Q37983791 | ||
| Splenomegaly in myelofibrosis--new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors | Q38031262 | ||
| Tumour-associated circulating microparticles: A novel liquid biopsy tool for screening and therapy monitoring of colorectal carcinoma and other epithelial neoplasia. | Q38874079 | ||
| Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm | Q39170744 | ||
| Microparticle-associated tissue factor activity: a link between cancer and thrombosis? | Q40260694 | ||
| Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis | Q40502054 | ||
| Scott syndrome: a disorder of platelet coagulant activity. | Q40577010 | ||
| Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms | Q44373577 | ||
| Time courses and value of circulating microparticles in patients with operable stage non-small cell lung cancer undergoing surgical intervention. | Q51124341 | ||
| Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis. | Q53092609 | ||
| Thrombosis in primary myelofibrosis: incidence and risk factors | Q61050096 | ||
| Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia | Q61050107 | ||
| Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer | Q79478642 | ||
| Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation status | Q79578111 | ||
| The presence of the JAK2 V617F mutation is associated with a higher haemoglobin and increased risk of thrombosis in essential thrombocythaemia | Q82200822 | ||
| Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism | Q83266217 | ||
| Short-term very low-calorie diet in obese females improves the haemostatic balance through the reduction of leptin levels, PAI-1 concentrations and a diminished release of platelet and leukocyte-derived microparticles | Q83567191 | ||
| Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism | Q84737551 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 2531-2536 | |
| P577 | publication date | 2017-06-22 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Clinical significance of circulating microparticles in Ph- myeloproliferative neoplasms | |
| P478 | volume | 14 |
| Q89655208 | Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm |
| Q52643454 | Platelet Microparticles and miRNA Transfer in Cancer Progression: Many Targets, Modes of Action, and Effects Across Cancer Stages |
| Q61814938 | Thrombin Generation and Cancer: Contributors and Consequences |
| Q91979063 | Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms |
Search more.